Available Resources

  • In vitro and in vivo efficacy studies and preclinical pharmacology
  • Various carcinogen-induced and genetically engineered animal models of cancer
  • Identification and evaluation of intermediate biomarkers
  • PK and PK/PD modeling to evaluate efficacy and optimize dosing regimen
  • Characterization of immune responses to vaccines and immunomodulatory agents
  • Formulation optimization for enhanced bioavailability and clinical usefulness
  • Analytical method development for investigational agents in bulk form and in biological fluids and tissues
  • Scale-up cGMP and non-cGMP production of an investigational agent
  • Stability testing for bulk and formulated material
  • Preclinical investigational new drug (IND)-directed GLP toxicology studies
  • Regulatory support
  • Other resources to support drug development

View the Prime Contractors 2019-2023 and Animal Models Used by PREVENT.